Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02048813
Brief Title: Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

First Submitted : January 27, 2014
First Submitted that Met QC Criteria : January 27, 2014
First Posted : January 29, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : September 25, 2021
Last Update Posted : September 28, 2021